Found 0 matching trials
Effects of Obesity Treatments on Food Preferences and Metabolism
N/AObesity and Type 2 Diabetes Mellitus are major health problems which are be...
Location
Royal Surrey County Hospital
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
N/ATo perform an observational analysis to emulate a target trial (i.e., a hyp...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
N/AThis study will compare hemoglobin a1c (HbA1c) and cardiovascular (CV) outc...
Location
Brigham and Women's Hospital
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
PHASE4A double-blinded, randomised, placebo-controlled trial of liraglutide 3.0 m...
Liraglutide and Peripheral Artery Disease
PHASE4STARDUST is an open-label, two-arm randomized controlled trial, aimed at ev...
Location
Unit of Endocrinology and Metabolic Diseases and Unit of Diabetes, University of Campania Luigi Vanvitelli
Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
PHASE4The aim of the study is to investigate the effects of preoperative Saxenda ...
Location
Multiple Locations
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
PHASE2This studay evaluates the effect of liraglutide in the treatment of obese p...
Location
Xiangya Hospital of Central South University
Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
PHASE4Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagonlike peptide-1 (GLP-1...
Location
Novartis Investigative Site
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
PHASE1Umbilical cord mesenchymal stem cells (SC) transplantation was a novel ther...
Location
Diabetes Care Center of Nanjing Military Command
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
N/APatients with type 2 diabetes (T2D) suffer from an excess risk of adverse c...
Location
Division of Metabolic Diseases, University Hospital of Padova